The most common type of immunotherapy occurs with immune checkpoint inhibitors (key regulators of the immune system) and has recently provided major advances in the care and treatment of cancer patients. William Osler Health System (Osler) has established a first-of-its-kind cancer Immunotherapy Program in Canada, where all patients starting immunotherapy receive comprehensive education and proactive care
Your browser does not support the video tag. 39th Annual Meeting & Pre-Conference Programs Nov. 6–10, 2024 | Houston, TX | #SITC24 April 24, 2024 Regular & Young Investigator Abstract Submissions Open May 2024 Registration Opens June 27, 2024 Regular & Young Investigator Abstract Submissions Close July 15, 2024 Late-Breaking Abstract Submissions Open Sept. 12, 2024 Late-Breaking Abstract Submissions Close Advance the science, discover breakthroughs and educate the world on cancer immunotherapy
Former President Jimmy Carter's success with immunotherapy for advanced melanoma and Vice President Joe Biden's Cancer Moonshot Initiative have brought this new treatment type, as well as cancer treatments in general, into the spot light for the general public. As a result, health care professionals may experience a spike in inquiries about this new treatment
ImmunotherapyforMelanomaProfessionaledition.pdf
SITC has responded to a recent Senate committee RFI related to rare diseases. SITC's full comments can be found included in the letter HERE .
The International Society for Biological Therapy of Cancer (iSBTc) 22 nd Annual Meeting November 2-4, 2007 Seaport World Trade Center in Boston, Massachusetts Program Organizers George Coukos, MD, PhD - University of Pennsylvania Medical Center F
35 attachments
See matching library entry files - Experimental Design dLN Spleen AGN2a MIFKD AGN2a...
During this month, we will bring attention to the many ways our society, through the contributions and dedication of its members, seeks to educate health care professionals and patients, and to enable research that will yield our field’s next breakthroughs
The International Society for Biological Therapy of Cancer 22 nd Annual Meeting: Dinner Symposium: Harnessing Immune Responses and Stem Cell Transplantation as a paradigm of Combination Therapy in Cancer Friday, November 2, 2007 Seaport World Trade Center in Boston, Massachusetts Program Organizers William J
3 attachments
Presentation slides and video from the 2023 Advances in Cancer Immunotherapy ™ Series: A Focus on Genitourinary Cancers were presented virtually on March 22, 2023. Program Organizers Michael Hurwitz, MD – Yale Cancer Center Tyler Stewart, MD – UC San Diego Tian Zhang, MD – UT Southwestern Medical Center Target Audience The Advances in Cancer Immunotherapy™ (ACI) programs aim to reach practicing clinical oncologists, nurses, nurse practitioners, advanced practitioners, pharmacists, emergency physicians, and other allied health professionals who wish to learn the basic principles of cancer immunotherapy and the most up-to-date clinical data for these treatments, in a multitude of disease states/therapeutic areas, in order to inform and integrate into their own clinical practice
14 attachments
See matching library entry files - Meeting: 2023 Advances in Cancer Immunotherapy™ ...
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us